Tirbanibulin Ointment Eradicates HPV-57 (+) Periungual Squamous Cell Carcinoma

Main Article Content

Angela Moore
Stephen Moore
Qin He
Peter Rady
Ayman Grada
Stephen Tyring

Keywords

Skin Cancer

Abstract

N/A

References

1. Fernandez Figueras MT. From actinic keratosis to squamous cell carcinoma:
pathophysiology revisited. J Eur Acad Dermatol Venereol. 2017;31 Suppl 2:5-7.
doi:10.1111/jdv.14151

2. Smolinski MP, Bu Y, Clements J, et al. Discovery of Novel Dual Mechanism of
Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-
361). J Med Chem. 2018;61(11):4704-4719. doi:10.1021/acs.jmedchem.8b00164

3. Smolinski MP, Bu Y, Clements J, et al. Discovery of Novel Dual Mechanism of
Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-
361). J Med Chem. 2018;61(11):4704-4719. doi:10.1021/acs.jmedchem.8b00164

4. Blauvelt A, Kempers S, Forman S, Lain E, Bruce S. Tirbanibulin Ointment 1%, a
Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the
Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies. J
of Skin. 2020;4(5):s63-s63. doi:10.25251/skin.4.supp.62

5. Moore AY, Moore S. Topical tirbanibulin eradication of periungual squamous cell
carcinoma. JAAD Case Reports. 2021;14:101-103. doi:10.1016/j.jdcr.2021.06.013

Most read articles by the same author(s)

<< < 1 2 3 > >>